BioCentury | Jan 1, 2021
Regulation

Another year of firsts in FDA’s new drug approvals

...in the U.S. also hits a hot new oncology...
BioCentury | Oct 6, 2020
Product Development

Reversing the impact of COVID-19 on oncology clinical trials

...trials could lead to two or three new oncology...
BioCentury | Aug 6, 2020
Politics, Policy & Law

BIO challenging its members to walk the talk on social justice

...Racial Diversity” ). For example, only 4% of the participants in trials of the 11 new oncology...
BioCentury | Apr 28, 2020
Finance

Merck’s adjusted revenue guidance shows product mix matters during COVID-19

...decline in patient well-visits and elective surgeries, plus smaller drops in urgent surgeries and even new oncology...
BioCentury | Feb 27, 2020
Finance

MPM, Dana-Farber forge philanthropic arrangement around new oncology funds

With the launch of two new funds, MPM Capital and Dana-Farber Cancer Institute each gain access to more of something they felt they were missing. As MPM invests its new $100 million Oncology Innovations Fund,...
BioCentury | Jan 13, 2020
Finance

All chips on immuno-oncology is not a good gamble

...would get approved by the FDA in the next 5-10 years, or 30 to 60 new oncology...
...in 2019. The agency would have to double its resources to approve 30 to 60 new oncology...
...Healthcare costs are the third problem. On a per patient basis, the cost of most new oncology...
BioCentury | Nov 7, 2019
Product Development

AZ replants R&D roots in China, goes all-in on innovation

...is off to a strong start, our new oncology...
BioCentury | Jul 19, 2019
Company News

Payers, patients coming on board for Novartis’ Zolgensma

...approvals, double-digit reimbursement, Entresto is doing well, Cosentyx is off to a strong start, our new oncology...
BioCentury | Sep 13, 2018
Financial News

Surface Oncology execs join MPM

...Biniszkiewicz and Scott Chappel as executive partners. They will be responsible for identifying and evaluating new oncology...
BioCentury | May 10, 2018
Politics & Policy

House primes for FDA budget boost

...million for FDA medical product safety activities, including an increase of $5 million for the new Oncology...
Items per page:
1 - 10 of 37
BioCentury | Jan 1, 2021
Regulation

Another year of firsts in FDA’s new drug approvals

...in the U.S. also hits a hot new oncology...
BioCentury | Oct 6, 2020
Product Development

Reversing the impact of COVID-19 on oncology clinical trials

...trials could lead to two or three new oncology...
BioCentury | Aug 6, 2020
Politics, Policy & Law

BIO challenging its members to walk the talk on social justice

...Racial Diversity” ). For example, only 4% of the participants in trials of the 11 new oncology...
BioCentury | Apr 28, 2020
Finance

Merck’s adjusted revenue guidance shows product mix matters during COVID-19

...decline in patient well-visits and elective surgeries, plus smaller drops in urgent surgeries and even new oncology...
BioCentury | Feb 27, 2020
Finance

MPM, Dana-Farber forge philanthropic arrangement around new oncology funds

With the launch of two new funds, MPM Capital and Dana-Farber Cancer Institute each gain access to more of something they felt they were missing. As MPM invests its new $100 million Oncology Innovations Fund,...
BioCentury | Jan 13, 2020
Finance

All chips on immuno-oncology is not a good gamble

...would get approved by the FDA in the next 5-10 years, or 30 to 60 new oncology...
...in 2019. The agency would have to double its resources to approve 30 to 60 new oncology...
...Healthcare costs are the third problem. On a per patient basis, the cost of most new oncology...
BioCentury | Nov 7, 2019
Product Development

AZ replants R&D roots in China, goes all-in on innovation

...is off to a strong start, our new oncology...
BioCentury | Jul 19, 2019
Company News

Payers, patients coming on board for Novartis’ Zolgensma

...approvals, double-digit reimbursement, Entresto is doing well, Cosentyx is off to a strong start, our new oncology...
BioCentury | Sep 13, 2018
Financial News

Surface Oncology execs join MPM

...Biniszkiewicz and Scott Chappel as executive partners. They will be responsible for identifying and evaluating new oncology...
BioCentury | May 10, 2018
Politics & Policy

House primes for FDA budget boost

...million for FDA medical product safety activities, including an increase of $5 million for the new Oncology...
Items per page:
1 - 10 of 37